generics
-
News
Generic drugs: Italians European champions for knowledge but not for use
“Gli italiani conoscono molto bene il sistema dei farmaci equivalenti, cosa che non trova riscontro in altri Paesi” MeteoWeb – 16…
Leggi » -
First floor
Swiss. There is a lack of patent-expired drugs. Branded companies are no longer convenient and China, which produces generics for the whole world, is unable to meet the demands
There is a shortage of (certain) medicines in Switzerland Swiss TV – 10 June 2019 In Switzerland, home to some of the…
Leggi » -
First floor
Swiss. Consumers are asking for the origin of the drug to be indicated on generic packaging
“Perché non ci dite l’origine dei farmaci?” La Svizzera chiama in causa Big Pharma Il Salvagente – 13 maggio 2019…
Leggi » -
First floor
USA. Teva and nineteen other generic pharmaceutical companies accused of rigging the price fixing system
WASHINGTON (Reuters) - The United States has filed a lawsuit accusing 20 drug companies of generics, including Teva…
Leggi » -
News
Great Pharma War: India criticizes US crusade against cheap generic drugs
La spinta di Washington per i diritti di proprietà intellettuale nell’industria farmaceutica è un attacco all’industria farmaceutica indiana, secondo New…
Leggi » -
First floor
Price of medicines: a reply to the Director of AIFA. With the fetish of transparency, the hedging difficulties of a State with delusions of omnipotence are unloaded on the sector
The medicines market is heavily regulated. Even before some specific strategies to contain pharmaceutical expenditure, such as…
Leggi » -
News
Tuscany Regional Administrative Court. Biologics and biosimilars are not identical. Automatic substitution is not allowed. Regional Resolution 194: excess of power and incompetence
Ancora una volta l’oggetto del contenzioso sono farmaci biologici e l’orientamento delle scelte prescrittive. I giudici accolgono il rilievo di…
Leggi » -
News
EMA communication on sartans: reviewing production processes to avoid probable carcinogenic pollutants
Companies that manufacture sartan blood pressure medications (also known as angiotensin II receptor blockers)…
Leggi » -
News
Chiazzese (M5S): what does the government intend to do to increase the sales of generic drugs? Minister Grillo: "strengthening information to increase its use" Editor's note
For information, we report the question below Oral answer question 3-00175 presented by CHIAZZESE Giuseppe Tuesday 18 September 2018, session…
Leggi » -
News
USA. Investors in Big Pharma are demanding higher profits. The financial limits of biotechnology and the pitfalls of generics
Big Pharma Tackles Curse of Billionaire Blockbuster Investors Demand Today's Extraordinarily Lucrative Drugs Have a…
Leggi »